Disease

Breast Carcinoma

8 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 20, 2026 · PHASE 2 TRIAL

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

ClinicalTrials.gov

Phase 2 interventional trial testing a mechanistic hypothesis (inflammation reduction) as surrogate for cancer prevention in an unstudied population; no results reported in registry record.

PreliminaryLow-Dose Aspirin Breast Carcinoma Mayo Clinic

Reported

Planned enrollment60

Study phasePhase 2

Primary outcome measureChange in pregnancy-related breast cancer (…

AUG 19, 2026 · INTERVENTIONAL STUDY

Mobile Health for Adherence in Breast Cancer Patients

ClinicalTrials.gov

This is an active clinical trial registration with no posted results; the study design and planned enrollment are sound, but no outcome data are yet available to assess efficacy.

PreliminaryHealth Promotion and Education ECOG-ACRIN Cancer Research Group Breast Carcinoma

Reported

Planned enrollment390

Primary outcome measureAdherence using electronic monitoring, asse…

Study typeInterventional

AUG 19, 2026 · INTERVENTIONAL STUDY

Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer

ClinicalTrials.gov

This is a registry record of a recruiting interventional study with no reported results; primary outcomes measure feasibility and adherence, not clinical efficacy.

PreliminaryRespiratory Muscle Training NCT05787834 Head and Neck Cancer

Reported

Planned enrollment130

Primary outcome measure 1Proportion of patients who participate in t…

Primary outcome measure 2Proportion of patients who remain on study,…

AUG 17, 2026 · INTERVENTIONAL STUDY

A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction

ClinicalTrials.gov

This is an active recruiting trial with no results reported; it is a feasibility and patient-reported outcome study in a small population with surrogate endpoints.

PreliminaryNCT07047872 Breast Carcinoma Mayo Clinic

Reported

Planned enrollment50

Primary outcome measure 1Patient-reported satisfaction with appearan…

Primary outcome measure 2Patient-reported emotional well-being at ba…

AUG 13, 2026 · INTERVENTIONAL STUDY

The Vanguard Study: Testing a New Way to Screen for Cancer

ClinicalTrials.gov

This is a feasibility registry record for a planned interventional study with no results reported; it describes study design and operational endpoints only, appropriate for preliminary classification of early-phase screening research.

PreliminaryDevice Usage Colorectal Carcinoma NCT06995898

Reported

Planned enrollment24000

Age range45–75 years

Study arms3 groups (2 MCD test groups and 1 control)

AUG 11, 2026 · INTERVENTIONAL STUDY

Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge

ClinicalTrials.gov

This is a clinical trial registry record with no reported results; the study is active but not recruiting, with planned enrollment of 40 participants and a primary outcome of CESM sensitivity that has not yet been published.

PreliminaryIodinated Contrast Agent Digital Tomosynthesis Mammography NCT05056844

Reported

Planned enrollment40

Primary outcome measureSensitivity of contrast enhancement of cont…

Follow-up durationan average of 1 year

AUG 7, 2026 · PHASE 1 TRIAL

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

ClinicalTrials.gov

Phase 1 trial registration with no results reported; study is active but not yet recruiting, evaluating safety and dosing of a novel AKT1 inhibitor in advanced cancers.

PreliminaryNCT07038369 Breast Carcinoma ATV-1601

Reported

Planned enrollment134

Study phasePhase 1

Primary outcome: safety and toler…Approximately 48 months

JUL 27, 2026 · OBSERVATIONAL STUDY

Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

ClinicalTrials.gov

Observational study collecting CSF and biospecimens from metastatic breast cancer patients to explore predictive markers; no results yet available.

PreliminaryMalignant Neoplasm of Breast National Cancer Institute (NCI)Breast Carcinoma

Reported

Estimated enrollment139

Primary outcome measureCollection of CSF samples

Study durationUp to 3 years